- AVEO Pharmaceuticals, Inc. stock price today and history
AVEO Pharmaceuticals, Inc. (AVEO) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
AVEO Pharmaceuticals, Inc. stock price
AVEO Pharmaceuticals, Inc. latest news:
BRIEF-Aveo Pharmaceuticals- Tivo-3 study will continue as planned without modification
* Aveo Pharmaceuticals Inc - announces completion of Tivo-3
study futility analysis with no changes to study protocol
AVEO Pharma stock rises 6% after cancer drug gets approved in Europe
AVEO Pharmaceuticals Inc. shares rose as much as 6.2% to $4.01 in extremely heavy morning trade Monday after the company's cancer drug was approved in Europe. The drug, Fotivda, was approved for adults with advanced renal cell carcinoma -- the most common type of kidney cancer -- in the European Union as well as Norway and Iceland. Fotivda is being licensed in Europe by Jazz Pharmaceuticals' EUSA Pharma Inc. The drug was recommended for approval by a scientific committee of the European Medicines Agency in late June, news that sent AVEO Pharma shares surging. AVEO Pharma shares have risen 426% over the last three months, compared with a 1.3% rise in the S&P 500 .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Aviat Networks, Inc.AVNW
Avid Technology, Inc.AVID
Avis Budget Group, Inc.CAR
Axcelis Technologies, Inc.ACLS
Axion Power International, Inc.AXPW
Axion Power International, Inc.AXPWW